SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain ClinVar gnomAD ESM1b AlphaMissense REVEL FoldX Rosetta Foldetta PremPS PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation DOI
Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Score Prediction Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.382C>AP128TLikely BenignUncertain 16-33432247-C-A16.20e-7-4.217Likely Benign0.267Likely BenignLikely Benign0.075Likely Benign-0.96Neutral0.952Possibly Damaging0.500Possibly Damaging4.19Benign0.35Tolerated3.744-100.93.99
c.3859C>AP1287TLikely BenignUncertain 16-33447907-C-A-3.940Likely Benign0.077Likely BenignLikely Benign0.044Likely Benign-0.22Neutral0.126Benign0.041Benign2.78Benign0.04Affected3.775-100.93.99
c.1221G>TQ407H
(3D Viewer)
Likely PathogenicC2Uncertain 1-10.526Likely Pathogenic0.830Likely PathogenicAmbiguous0.206Likely Benign0.59Ambiguous0.00.61Ambiguous0.60Ambiguous1.10Destabilizing-4.51Deleterious0.982Probably Damaging0.947Probably Damaging3.88Benign0.01Affected3.3828030.39.01
c.2724G>CQ908HLikely BenignConflicting 46-33443276-G-C16.20e-7-4.658Likely Benign0.311Likely BenignLikely Benign0.112Likely Benign-0.74Neutral0.996Probably Damaging0.995Probably Damaging2.58Benign0.05Affected3.775300.39.01
c.3192G>CQ1064HLikely BenignUncertain 1-4.576Likely Benign0.162Likely BenignLikely Benign0.063Likely Benign-0.66Neutral0.938Possibly Damaging0.596Possibly Damaging4.15Benign0.05Affected300.39.01
c.1153T>CS385P
(3D Viewer)
Likely BenignC2Uncertain 16-33438058-T-C-5.431Likely Benign0.123Likely BenignLikely Benign0.385Likely Benign0.91Ambiguous0.6-0.90Ambiguous0.01Likely Benign0.19Likely Benign-0.26Neutral0.676Possibly Damaging0.693Possibly Damaging4.63Benign0.04Affected4.3231-1-0.810.04210.318.51.80.90.30.0UncertainSer385 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and so they are rich in glycine residues, prolines, and, to a lesser extent, small hydrophilic residues to ensure maximum flexibility. Thus, the variant’s Pro385 is potentially tolerated in the Ω loop. However, since the effects on Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1558T>CS520P
(3D Viewer)
Likely PathogenicGAPUncertain 1-12.707Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.855Likely Pathogenic3.72Destabilizing0.88.86Destabilizing6.29Destabilizing0.83Ambiguous-4.57Deleterious0.997Probably Damaging0.986Probably Damaging-1.32Pathogenic0.01Affected1-1-0.810.04
c.1600T>CS534P
(3D Viewer)
Likely BenignGAPUncertain 16-33438843-T-C31.86e-6-5.056Likely Benign0.265Likely BenignLikely Benign0.203Likely Benign-0.40Likely Benign0.20.35Likely Benign-0.03Likely Benign0.47Likely Benign-3.81Deleterious0.993Probably Damaging0.993Probably Damaging3.32Benign0.05Affected3.3735-11-0.810.04
c.2068T>CS690P
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.568Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.431Likely Benign4.84Destabilizing0.34.40Destabilizing4.62Destabilizing1.42Destabilizing-4.77Deleterious0.998Probably Damaging0.790Possibly Damaging3.44Benign0.01Affected3.42171-1-0.810.04207.515.10.10.0-0.10.2XXPotentially PathogenicThe hydroxyl side chain of Ser690, located in an α-helix (res. Leu696-Leu685), forms a hydrogen bond with the backbone carbonyl group of Ser410 in an anti-parallel β-sheet of the C2 domain (res. Ile411-Ala399). In the variant simulations, the pyrrolidine side chain of Pro690 cannot form hydrogen bonds with the C2 domain residue, resulting in the loss of this inter-domain connection. Additionally, prolines lack a free amide group necessary for hydrogen bonding with the carbonyl group of Gly686, introducing a slight bend in the α-helix and compromising its integrity.
c.2863T>CS955PLikely BenignUncertain 16-33443415-T-C31.86e-6-2.584Likely Benign0.073Likely BenignLikely Benign0.098Likely Benign-0.75Neutral0.001Benign0.004Benign2.33Pathogenic0.00Affected3.7751-1-0.810.04
c.313T>CS105PLikely BenignUncertain 1-3.631Likely Benign0.166Likely BenignLikely Benign0.204Likely Benign0.03Neutral0.808Possibly Damaging0.212Benign4.00Benign0.00Affected4.321-11-0.810.04
c.3394T>CS1132PLikely BenignConflicting 36-33443946-T-C16.74e-7-1.423Likely Benign0.144Likely BenignLikely Benign0.301Likely Benign0.38Neutral0.003Benign0.006Benign5.40Benign0.28Tolerated4.3241-1-0.810.04
c.3424T>CS1142PLikely BenignLikely Benign 16-33444459-T-C16.20e-7-2.713Likely Benign0.222Likely BenignLikely Benign0.107Likely Benign-2.19Neutral0.918Possibly Damaging0.761Possibly Damaging2.64Benign0.00Affected4.324-11-0.810.04
c.82T>CS28PLikely BenignUncertain 1-3.309Likely Benign0.051Likely BenignLikely Benign0.047Likely Benign1.37Neutral0.000Benign0.000Benign4.53Benign0.00Affected4.3211-1-0.810.04
c.703T>CS235P
(3D Viewer)
Likely PathogenicPHLikely Pathogenic 1-14.857Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.870Likely Pathogenic4.02Destabilizing0.16.91Destabilizing5.47Destabilizing1.23Destabilizing-4.24Deleterious0.917Possibly Damaging0.446Benign5.47Benign0.01Affected3.40141-1-0.810.04201.517.00.10.0-0.60.0XPotentially PathogenicIn the WT, the hydroxyl group of Ser235, located in a β-α loop between an anti-parallel β sheet strand (res. Gly227-Phe231) and an α helix (residues Ala236-Val250), forms hydrogen bonds with the GAP domain loop residue Glu680 and with the backbone amide groups of Ala237 and Glu238 from the α helix. In the variant simulations, the pyrrolidine ring of Pro235 cannot stabilize the α helix end or maintain tertiary bonding interactions between the PH and GAP domains via hydrogen bonding as effectively as serine.
c.2168C>TT723I
(3D Viewer)
Likely BenignGAPLikely Benign 16-33441633-C-T21.24e-6-2.591Likely Benign0.120Likely BenignLikely Benign0.045Likely Benign-0.39Likely Benign0.0-0.20Likely Benign-0.30Likely Benign0.26Likely Benign-2.09Neutral0.088Benign0.030Benign3.39Benign0.03Affected3.5080-15.212.05252.3-31.60.00.0-0.20.2XUncertainThe hydroxyl group of Thr723, located on the outer surface of an α-helix (res. Leu714-Arg726), continuously forms hydrogen bonds with the backbone carbonyl of Asn719 in the WT simulations, potentially lowering the stability of the α-helix. In the variant simulations, the sec-butyl side chain of Ile723 cannot form any hydrogen bonds, which, in theory, could increase the helix stability. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2924C>TT975ILikely BenignUncertain 16-33443476-C-T63.72e-6-3.912Likely Benign0.164Likely BenignLikely Benign0.068Likely Benign-1.66Neutral0.411Benign0.239Benign4.11Benign0.66Tolerated4.3220-15.212.05
c.3053C>TT1018IUncertain 16-33443605-C-T42.48e-6-3.264Likely Benign0.524AmbiguousLikely Benign0.076Likely Benign-2.55Deleterious0.586Possibly Damaging0.304Benign2.24Pathogenic0.01Affected3.775-105.212.05
c.1040C>AT347N
(3D Viewer)
Likely BenignC2Uncertain 16-33437945-C-A95.58e-6-5.545Likely Benign0.165Likely BenignLikely Benign0.059Likely Benign0.41Likely Benign0.10.46Likely Benign0.44Likely Benign-0.06Likely Benign1.96Neutral0.001Benign0.001Benign1.67Pathogenic0.60Tolerated3.372500-2.813.00
c.1055C>AT352N
(3D Viewer)
Likely BenignC2Likely Benign 16-33437960-C-A21.24e-6-4.817Likely Benign0.117Likely BenignLikely Benign0.027Likely Benign0.20Likely Benign0.0-0.04Likely Benign0.08Likely Benign0.45Likely Benign-0.92Neutral0.255Benign0.057Benign1.75Pathogenic0.19Tolerated3.372500-2.813.00208.4-14.5-0.20.1-0.10.0XPotentially BenignThr352 is located in a short α helical section within a loop connecting two β strands (res. Gly341-Pro349, res. Thr359-Pro364) originating from two different anti-parallel β sheets of the C2 domain. In the WT simulations, the side chain hydroxyl and backbone amide groups of Thr354 form hydrogen bonds with the backbone carbonyl group of Pro349 at the end of the preceding β strand. This arrangement likely stabilizes the α helical section and aids in folding, keeping the short secondary structure element intact in the variant simulations. However, the carboxamide group of the Asn352 side chain does not form hydrogen bonds with the backbone carbonyl group of Pro349. Instead, it packs against the cyclic ring and forms hydrogen bonds with the phenol group of the Tyr363 side chain in the other β strand.
c.2369C>AT790NSH3-binding motifConflicting 36-33442921-C-A694.28e-5-5.243Likely Benign0.276Likely BenignLikely Benign0.103Likely Benign-2.54Deleterious0.999Probably Damaging0.997Probably Damaging2.27Pathogenic0.02Affected3.64600-2.813.00
c.2735C>AT912NLikely BenignUncertain 1-4.260Likely Benign0.190Likely BenignLikely Benign0.116Likely Benign-1.15Neutral0.999Probably Damaging0.977Probably Damaging3.96Benign0.00Affected3.77500-2.813.00
c.2924C>AT975NLikely BenignUncertain 16-33443476-C-A16.20e-7-4.671Likely Benign0.089Likely BenignLikely Benign0.100Likely Benign-0.58Neutral0.586Possibly Damaging0.302Benign4.13Benign0.07Tolerated4.32200-2.813.00
c.458C>AT153NLikely BenignConflicting 3-0.739Likely Benign0.226Likely BenignLikely Benign0.161Likely Benign0.88Neutral0.888Possibly Damaging0.537Possibly Damaging4.23Benign0.81Tolerated3.61500-2.813.00
c.1027G>AV343I
(3D Viewer)
Likely BenignC2Uncertain 26-33437932-G-A16.20e-7-6.020Likely Benign0.117Likely BenignLikely Benign0.020Likely Benign-0.27Likely Benign0.0-0.04Likely Benign-0.16Likely Benign-0.39Likely Benign-0.14Neutral0.159Benign0.084Benign1.98Pathogenic0.27Tolerated3.3725430.314.03240.2-26.9-0.20.2-0.20.2XPotentially BenignThe iso-propyl side chain of Val343, located in an anti-parallel β sheet strand (res. Gly341-Pro349), is packing against multiple hydrophobic residues of the C2 domain (e.g., Leu327, Leu274, Val365). In the variant simulations, the sec-butyl side chain of Ile343 is basically able to form the same interactions as valine due to its similar hydrophobic profile. The residue swap also does not seem to cause negative effects on the protein structure based on the simulations.
c.103G>AV35ILikely BenignUncertain 16-33423512-G-A53.10e-6-3.764Likely Benign0.081Likely BenignLikely Benign0.017Likely Benign-0.32Neutral0.672Possibly Damaging0.369Benign4.16Benign0.00Affected4.321340.314.03
c.1300G>AV434I
(3D Viewer)
Likely BenignGAPUncertain 16-33438205-G-A16.19e-7-6.999Likely Benign0.129Likely BenignLikely Benign0.192Likely Benign-0.04Likely Benign0.00.22Likely Benign0.09Likely Benign0.31Likely Benign-0.82Neutral0.947Possibly Damaging0.851Possibly Damaging3.53Benign0.18Tolerated3.3729430.314.03246.7-27.70.00.00.10.0XPotentially BenignThe iso-propyl side chain of Val434, located at the end of an α helix (res. Met414-Glu436), packs against hydrophobic residues in an interhelix space (e.g., Met430, Ala707, Leu711). In the variant simulations, the sec-butyl group of Ile434 is able to form the same hydrophobic interactions. Accordingly, the residue swap does not negatively affect the protein structure based on the simulations.
c.1339G>CV447L
(3D Viewer)
Likely BenignGAPUncertain 1-5.136Likely Benign0.491AmbiguousLikely Benign0.180Likely Benign-1.13Ambiguous0.10.54Ambiguous-0.30Likely Benign0.03Likely Benign-0.29Neutral0.947Possibly Damaging0.851Possibly Damaging3.61Benign0.90Tolerated3.373212-0.414.03
c.1354G>AV452I
(3D Viewer)
GAPUncertain 1-8.985Likely Pathogenic0.361AmbiguousLikely Benign0.218Likely Benign-0.08Likely Benign0.10.51Ambiguous0.22Likely Benign0.25Likely Benign-0.99Neutral0.947Possibly Damaging0.851Possibly Damaging3.26Benign0.05Affected430.314.03
c.1417G>AV473I
(3D Viewer)
GAPUncertain 16-33438449-G-A16.20e-7-7.481In-Between0.418AmbiguousLikely Benign0.203Likely Benign-0.12Likely Benign0.01.20Ambiguous0.54Ambiguous-0.06Likely Benign-0.91Neutral0.929Possibly Damaging0.917Probably Damaging3.74Benign0.18Tolerated3.3734340.314.03
c.1198G>CV400L
(3D Viewer)
Likely BenignC2Benign 16-33438103-G-C221.36e-5-1.000Likely Benign0.137Likely BenignLikely Benign0.325Likely Benign-0.71Ambiguous0.20.39Likely Benign-0.16Likely Benign-0.29Likely Benign-0.60Neutral0.001Benign0.001Benign5.33Benign0.64Tolerated3.382721-0.414.03251.0-30.10.00.00.70.1XPotentially BenignThe iso-propyl side chain of Val400, located in an anti-parallel β sheet strand (res. Ala399-Ile411), hydrophobically packs against hydrophobic residues within the anti-parallel β sheet of the C2 domain (e.g., Ile268, Ala404, Leu325, Leu402). Val400 is swapped for another hydrophobic residue, leucine, whose branched hydrocarbon side chain is of a comparable size and thus packs favorably within the C2 domain. In short, the residue swap has no apparent negative effect on the structure based on the variant simulations.10.1016/j.ajhg.2020.11.011
c.1663G>AV555I
(3D Viewer)
Likely BenignGAPUncertain 1-4.544Likely Benign0.084Likely BenignLikely Benign0.253Likely Benign-0.82Ambiguous0.0-0.41Likely Benign-0.62Ambiguous-0.55Ambiguous0.45Neutral0.002Benign0.002Benign-1.26Pathogenic1.00Tolerated430.314.03
c.1702G>TV568L
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.503Likely Pathogenic0.921Likely PathogenicAmbiguous0.651Likely Pathogenic-0.30Likely Benign0.30.57Ambiguous0.14Likely Benign0.56Ambiguous-2.69Deleterious0.511Possibly Damaging0.147Benign-1.23Pathogenic0.04Affected3.373512-0.414.03
c.1604G>CS535T
(3D Viewer)
Likely BenignGAPBenign 16-33438847-G-C148.67e-6-3.886Likely Benign0.069Likely BenignLikely Benign0.177Likely Benign0.45Likely Benign0.1-0.27Likely Benign0.09Likely Benign0.17Likely Benign-0.81Neutral0.000Benign0.001Benign-1.25Pathogenic0.25Tolerated3.3735110.114.03201.3-17.3-0.10.7-0.20.1XPotentially BenignSer535 is located near the terminal end of an α-helix (res. Ala533-Val560) close to the membrane interface. In the WT simulations, the hydroxyl side chain of Ser535 forms hydrogen bonds with nearby residues (e.g., His539, Glu538) without any specific interactions. These hydrogen bonds disrupt the structure of the terminal end of the α-helix (Ala533-Ser535), causing it to weaken or unfold during the WT simulations. In the variant simulations, Thr535, a hydrophilic residue with a hydroxyl group of almost the same size as Ser, interacts more frequently with the preceding loop residues (e.g., Thr532, Cys531) due to its longer side chain. Regardless, the residue swap is tolerated in the simulations with no negative effects. However, due to its location near the SynGAP-membrane interface, the effect of the residue swap cannot be fully addressed using the SynGAP solvent-only simulations.10.1016/j.ajhg.2020.11.011
c.2111G>CS704T
(3D Viewer)
Likely BenignGAPUncertain 1-4.930Likely Benign0.265Likely BenignLikely Benign0.071Likely Benign0.80Ambiguous0.00.15Likely Benign0.48Likely Benign0.29Likely Benign-1.72Neutral0.525Possibly Damaging0.107Benign3.45Benign0.07Tolerated3.4710110.114.03201.7-18.00.00.0-0.20.7XPotentially BenignSer704 is located at the end and outer surface of an α-helix (res. Thr704-Gly712), which is connected via a tight turn or loop to another α-helix (res. Asp684-Gln702). The hydroxyl side chain of Ser704 occasionally forms a hydrogen bond with the amide group of Ala707. Similarly, in the variant simulations, the hydroxyl side chain of Thr704 forms hydrogen bonds with the amide groups of Ala707 and Leu708. Thus, the residue swap does not cause any apparent structural change.
c.2239G>CV747LLikely BenignUncertain 16-33441704-G-C21.24e-6-2.790Likely Benign0.096Likely BenignLikely Benign0.047Likely Benign-0.52Neutral0.065Benign0.033Benign2.67Benign0.00Affected4.32221-0.414.03
c.2270G>CG757ALikely BenignUncertain 1-2.626Likely Benign0.091Likely BenignLikely Benign0.066Likely Benign-0.45Neutral0.267Benign0.127Benign2.73Benign0.35Tolerated102.214.03
c.2362T>AS788TLikely BenignSH3-binding motifUncertain 26-33442914-T-A42.49e-6-4.288Likely Benign0.288Likely BenignLikely Benign0.092Likely Benign-2.25Neutral0.979Probably Damaging0.982Probably Damaging1.55Pathogenic0.02Affected3.646110.114.03
c.256G>AV86ILikely BenignUncertain 1-4.726Likely Benign0.338Likely BenignLikely Benign0.076Likely Benign-0.31Neutral0.267Benign0.097Benign3.94Benign0.00Affected4.321430.314.03
c.2578G>AV860ILikely BenignBenign 16-33443130-G-A211.30e-5-4.516Likely Benign0.095Likely BenignLikely Benign0.039Likely Benign-0.42Neutral0.009Benign0.006Benign4.24Benign0.00Affected3.775430.314.03
c.2596G>AV866ILikely BenignConflicting 36-33443148-G-A53.10e-6-4.652Likely Benign0.118Likely BenignLikely Benign0.059Likely Benign-0.39Neutral0.957Probably Damaging0.541Possibly Damaging2.69Benign0.27Tolerated3.824430.314.03
c.2596G>TV866LLikely BenignUncertain 16-33443148-G-T16.20e-7-3.352Likely Benign0.148Likely BenignLikely Benign0.046Likely Benign-0.97Neutral0.217Benign0.229Benign2.71Benign0.21Tolerated3.82421-0.414.03
c.2729G>CG910ALikely BenignUncertain 16-33443281-G-C16.20e-7-3.587Likely Benign0.361AmbiguousLikely Benign0.209Likely Benign-1.43Neutral0.999Probably Damaging0.999Probably Damaging2.78Benign0.10Tolerated3.775102.214.03
c.2840G>CG947ALikely BenignLikely Benign 16-33443392-G-C281.73e-5-6.511Likely Benign0.080Likely BenignLikely Benign0.156Likely Benign-0.41Neutral0.224Benign0.131Benign4.97Benign0.10Tolerated4.324102.214.03
c.3048C>AD1016ELikely BenignLikely Benign 16-33443600-C-A21.24e-6-3.422Likely Benign0.216Likely BenignLikely Benign0.017Likely Benign-0.37Neutral0.008Benign0.028Benign2.64Benign0.65Tolerated3.775230.014.03
c.3176G>CG1059ALikely BenignUncertain 16-33443728-G-C42.49e-6-6.754Likely Benign0.081Likely BenignLikely Benign0.329Likely Benign-0.17Neutral0.001Benign0.002Benign2.56Benign0.00Affected4.322102.214.03
c.335G>CG112ALikely BenignUncertain 16-33432200-G-C159.30e-6-2.456Likely Benign0.119Likely BenignLikely Benign0.114Likely Benign-2.34Neutral0.231Benign0.054Benign4.07Benign0.00Affected3.615102.214.03
c.3374G>CG1125ALikely BenignUncertain 16-33443926-G-C16.68e-7-6.569Likely Benign0.083Likely BenignLikely Benign0.232Likely Benign-0.60Neutral0.999Probably Damaging0.995Probably Damaging4.60Benign0.11Tolerated3.775102.214.03
c.3380G>CG1127ALikely BenignConflicting 46-33443932-G-C42.68e-6-5.949Likely Benign0.080Likely BenignLikely Benign0.164Likely Benign-0.43Neutral0.001Benign0.002Benign4.83Benign1.00Tolerated4.324102.214.03
c.453C>AD151ELikely BenignUncertain 1-5.662Likely Benign0.886Likely PathogenicAmbiguous0.142Likely Benign-2.02Neutral0.984Probably Damaging0.967Probably Damaging3.99Benign0.11Tolerated3.615320.014.03
c.603T>AD201E
(3D Viewer)
Likely BenignPHBenign 1-2.640Likely Benign0.406AmbiguousLikely Benign0.165Likely Benign0.42Likely Benign0.21.99Ambiguous1.21Ambiguous0.23Likely Benign-0.69Neutral0.633Possibly Damaging0.108Benign4.30Benign1.00Tolerated3.469320.014.03258.7-24.80.90.1-0.30.2XUncertainAsp201, an acidic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another acidic residue, glutamate. The carboxylate groups of both Asp201 and Glu201 side chains form hydrogen bonds with the hydroxyl group of Ser221 in the simulations. Due to its shorter side chain, Asp201 can also hydrogen bond with the backbone amide groups of neighboring loop residues Ser204 and Asp203. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.603T>GD201E
(3D Viewer)
Likely BenignPHConflicting 26-33435245-T-G201.24e-5-2.640Likely Benign0.406AmbiguousLikely Benign0.165Likely Benign0.42Likely Benign0.21.99Ambiguous1.21Ambiguous0.23Likely Benign-0.69Neutral0.633Possibly Damaging0.108Benign4.30Benign1.00Tolerated3.469320.014.03258.7-24.80.90.1-0.30.2XUncertainAsp201, an acidic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another acidic residue, glutamate. The carboxylate groups of both Asp201 and Glu201 side chains form hydrogen bonds with the hydroxyl group of Ser221 in the simulations. Due to its shorter side chain, Asp201 can also hydrogen bond with the backbone amide groups of neighboring loop residues Ser204 and Asp203. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.70G>AV24ILikely BenignUncertain 16-33423479-G-A95.58e-6-3.701Likely Benign0.137Likely BenignLikely Benign0.069Likely Benign-0.25Neutral0.043Benign0.031Benign3.96Benign0.00Affected4.321340.314.03
c.958G>AV320I
(3D Viewer)
Likely BenignC2Uncertain 1-5.220Likely Benign0.111Likely BenignLikely Benign0.027Likely Benign-0.27Likely Benign0.20.66Ambiguous0.20Likely Benign0.01Likely Benign-0.21Neutral0.198Benign0.114Benign1.77Pathogenic0.45Tolerated3.3823340.314.03
c.958G>CV320L
(3D Viewer)
C2Uncertain 16-33437863-G-C63.72e-6-6.207Likely Benign0.362AmbiguousLikely Benign0.096Likely Benign-0.26Likely Benign0.21.33Ambiguous0.54Ambiguous0.51Ambiguous-1.02Neutral0.900Possibly Damaging0.373Benign1.78Pathogenic0.92Tolerated3.382321-0.414.03245.8-10.20.30.90.10.3XPotentially BenignThe isopropyl side chain of Val310, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Thr305-Asn315, res. Ala322-Asp330), hydrophobically packs with the side chains of nearby residues (e.g., Leu286, Val350, Pro318). The hydrophobic Leu320 side chain mostly forms the same interactions; hence, the residue swap does not seem to negatively affect the protein structure based on the variant simulations.
c.2514C>AN838KLikely PathogenicUncertain 2-8.470Likely Pathogenic0.862Likely PathogenicAmbiguous0.097Likely Benign-2.78Deleterious0.997Probably Damaging0.995Probably Damaging2.69Benign0.16Tolerated3.77510-0.414.07
c.597C>AN199K
(3D Viewer)
PHUncertain 1-8.198Likely Pathogenic0.686Likely PathogenicLikely Benign0.024Likely Benign-0.19Likely Benign0.10.03Likely Benign-0.08Likely Benign0.33Likely Benign-1.48Neutral0.276Benign0.083Benign4.27Benign0.13Tolerated3.47910-0.414.07207.821.5-0.11.50.10.0XUncertainAsn199, located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by a positively charged lysine. On the protein surface, both the carboxamide group of Asn199 and the amino group of Lys199 side chains can form hydrogen bonds with the backbone carbonyl groups of residues (e.g., Ala249) at the end of an α helix (res. Ala236-Lys251). However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.1784T>AL595Q
(3D Viewer)
Likely PathogenicGAPUncertain 1-15.101Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.733Likely Pathogenic0.79Ambiguous0.11.40Ambiguous1.10Ambiguous1.99Destabilizing-5.97Deleterious1.000Probably Damaging1.000Probably Damaging2.75Benign0.00Affected3.3735-2-2-7.314.97
c.1964T>AL655Q
(3D Viewer)
Likely BenignGAPUncertain 1-5.278Likely Benign0.144Likely BenignLikely Benign0.139Likely Benign-0.01Likely Benign0.00.69Ambiguous0.34Likely Benign-0.15Likely Benign0.61Neutral0.955Possibly Damaging0.602Possibly Damaging3.59Benign0.65Tolerated3.3924-2-2-7.314.97229.9-8.60.00.00.40.0XPotentially BenignThe iso-butyl side chain of Leu655, located on the surface of an α helix (res. Ser641-Glu666), is not involved in any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Gln655 dynamically interacts with neighboring residues (e.g., Glu651, Glu656, Arg544) on the protein surface, with no negative structural effects.
c.2075T>AL692Q
(3D Viewer)
Likely PathogenicGAPPathogenic 1-13.873Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.596Likely Pathogenic3.24Destabilizing0.13.27Destabilizing3.26Destabilizing2.76Destabilizing-5.98Deleterious1.000Probably Damaging0.998Probably Damaging3.06Benign0.00Affected3.4217-2-2-7.314.97
c.791T>AL264Q
(3D Viewer)
Likely PathogenicC2Uncertain 1-15.729Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.678Likely Pathogenic3.43Destabilizing0.12.41Destabilizing2.92Destabilizing2.48Destabilizing-5.52Deleterious1.000Probably Damaging0.999Probably Damaging0.49Pathogenic0.00Affected3.3818-2-2-7.314.97254.7-7.60.00.00.00.3XXXPotentially PathogenicThe iso-butyl branched hydrocarbon side chain of Leu264, located at the end of an anti-parallel β sheet strand (res. Arg259-Arg272), packs against multiple hydrophobic residues such as Leu266, Phe314, Leu317, and Leu323 in the WT simulations. In the variant simulations, the hydrophilic carboxamide group of the Gln264 side chain is not suitable for the hydrophobic niche, causing the hydrophobic residues to make room for the swapped residue. Additionally, the carboxamide group of Gln264 forms hydrogen bonds with the backbone amide groups of Arg405 and Lys256 in the β sheet and the carbonyl group of Val350 in an α helical section of a nearby loop (res. Pro359-Phe358). The residue swap disrupts the packing of the C2 domain, which could adversely affect the C2 domain structure during folding. This disruption could potentially weaken the stability of the SynGAP-membrane association.
c.821T>AL274Q
(3D Viewer)
Likely PathogenicC2Uncertain 1-15.518Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.774Likely Pathogenic2.54Destabilizing0.31.74Ambiguous2.14Destabilizing1.97Destabilizing-5.42Deleterious1.000Probably Damaging0.999Probably Damaging0.00Pathogenic0.00Affected3.3819-2-2-7.314.97245.91.80.00.00.10.2XXXPotentially PathogenicThe aliphatic side chain of Leu274, located in a β hairpin loop (res. Glu273-Lys278) connecting two anti-parallel β sheet strands, packs against multiple hydrophobic residues facing the β sheet (e.g., Ala271, Leu327, Tyr280, Val306). The hydrophilic carboxamide group of the Gln274 side chain is not suitable for this hydrophobic niche, causing nearby residues to adjust to make room for the hydrophilic glutamine. Additionally, a new hydrogen bond forms with the backbone carboxyl group of Arg272 in another β strand (res. Glu273-Arg259).As a result, the backbone amide group of Ala399 and the carbonyl group of Arg272, which connect two β strands at the β sheet end, form fewer hydrogen bonds in the variant than in the WT simulations. Although no major secondary structure disruption is observed in the variant simulations, the residue swap could profoundly affect the C2 domain folding, as the hydrophobic packing of Leu274 is crucial for maintaining the loop's contact with the rest of the C2 domain. Lastly, because the Leu274-containing loop faces the membrane surface, the residue swap could also negatively impact the SynGAP-membrane association.
c.3233T>AV1078DLikely BenignUncertain 1-5.155Likely Benign0.979Likely PathogenicLikely Pathogenic0.158Likely Benign-1.45Neutral0.003Benign0.008Benign3.84Benign0.00Affected3.775-3-2-7.715.96
c.917T>AV306D
(3D Viewer)
Likely PathogenicC2Uncertain 1-18.289Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.530Likely Pathogenic4.40Destabilizing0.34.29Destabilizing4.35Destabilizing2.44Destabilizing-5.44Deleterious1.000Probably Damaging0.999Probably Damaging1.74Pathogenic0.00Affected3.3819-2-3-7.715.96212.3-18.3-0.20.40.00.2XXXPotentially PathogenicThe isopropyl group of Val396, located at the beginning of an anti-parallel β sheet strand (res. Thr305-Asn315), packs against multiple hydrophobic residues (e.g., Leu274, Trp308, Ala271) in the WT simulations. However, in the variant simulations, the negatively charged carboxylate group of the Asp306 side chain is not suitable for this hydrophobic niche. Consequently, the side chain moves out to interact with Ser300 in the β strand (res. Met289-Arg299) and the guanidinium group of Arg299 in the β hairpin loop.In the third simulation, the residue swap disrupts the C2 domain secondary structure and tertiary assembly to a large degree when the amino group of the Lys297 side chain rotates to form a salt bridge with Asp306. This drastic effect could potentially reflect the challenge presented by the residue swap during the C2 domain folding. Because the residue swap affects the C2 domain structure, the SynGAP-membrane association could also be impacted. However, this is beyond the scope of the solvent-only simulations to unravel.
c.3238G>TA1080SLikely BenignUncertain 16-33443790-G-T16.26e-7-3.277Likely Benign0.108Likely BenignLikely Benign0.103Likely Benign0.01Neutral0.702Possibly Damaging0.346Benign4.16Benign0.08Tolerated3.77511-2.616.00
c.4021G>TA1341SLikely BenignUncertain 16-33451895-G-T-2.867Likely Benign0.078Likely BenignLikely Benign0.099Likely Benign0.80Neutral0.000Benign0.001Benign4.40Benign1.00Tolerated3.77511-2.616.00
c.113C>TP38LLikely BenignConflicting 46-33423522-C-T84.96e-6-2.469Likely Benign0.197Likely BenignLikely Benign0.141Likely Benign-2.56Deleterious0.983Probably Damaging0.931Probably Damaging4.02Benign0.00Affected4.321-3-35.416.04
c.1193C>TP398L
(3D Viewer)
C2Uncertain 16-33438098-C-T84.96e-6-7.518In-Between0.547AmbiguousLikely Benign0.599Likely Pathogenic1.48Ambiguous0.2-0.54Ambiguous0.47Likely Benign0.62Ambiguous-7.10Deleterious0.961Probably Damaging0.256Benign5.72Benign0.01Affected3.4016-3-35.416.04245.8-68.6-0.10.0-0.30.2XPotentially PathogenicPro398 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364 and res. Ala399-Ile411). The Ω loop is assumed to directly interact with the membrane, and it is observed to move arbitrarily throughout the WT solvent simulations. Although the residue swap does not influence the nearby secondary structure elements, proline is often found at the ends of β sheets due to its disfavored status during folding.Additionally, the Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone. Ω loops are known to play significant roles in protein functions that require flexibility, and thus hydrophobic residues like leucine are rarely tolerated. Although no negative structural effects are visualized in the variant’s simulations, Leu398 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. Since the effects on the Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1685C>TP562L
(3D Viewer)
Likely PathogenicGAPPathogenic/Likely path. 106-33440737-C-T-13.438Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.829Likely Pathogenic3.54Destabilizing0.80.17Likely Benign1.86Ambiguous-0.14Likely Benign-9.95Deleterious1.000Probably Damaging1.000Probably Damaging0.58Pathogenic0.00Affected3.3735-3-35.416.04228.8-68.5-0.10.00.10.2XPotentially PathogenicPro562 is located on an α-α loop between two α-helices (res. Ala533-Val560 and res. Arg563-Glu578). The cyclic pyrrolidine side chain of Pro562 hydrophobically packs with other residues in the inter-helix space, such as Leu565, Ile501, and Phe561. In the variant simulations, Leu562 packs more favorably with the nearby hydrophobic residues, and the backbone amide group of Leu562 (absent in proline) does not form any intra-protein hydrogen bonds. However, prolines are well-suited for unstructured regions like loops, and thus, Pro562 in the WT is necessary at the end of the helix to induce a tight turn during folding. Although no negative structural effects are observed during the simulations, the residue swap could potentially cause extensive damage to the protein structure during folding.10.1016/j.ajhg.2020.11.011
c.2381C>TP794LLikely BenignSH3-binding motifBenign/Likely benign 26-33442933-C-T734.52e-5-3.808Likely Benign0.079Likely BenignLikely Benign0.075Likely Benign-0.80Neutral0.761Possibly Damaging0.321Benign4.24Benign0.03Affected4.073-3-35.416.04
c.2393C>TP798LLikely BenignSH3-binding motifUncertain 26-33442945-C-T63.72e-6-5.640Likely Benign0.074Likely BenignLikely Benign0.042Likely Benign-0.86Neutral0.981Probably Damaging0.631Possibly Damaging4.21Benign0.00Affected4.321-3-35.416.04
c.266C>TP89LUncertain 2-6.775Likely Benign0.982Likely PathogenicLikely Pathogenic0.119Likely Benign-3.29Deleterious0.889Possibly Damaging0.058Benign3.73Benign0.00Affected4.321-3-35.416.04
c.2822C>TP941LLikely BenignUncertain 2-5.692Likely Benign0.066Likely BenignLikely Benign0.054Likely Benign-0.44Neutral0.144Benign0.039Benign2.76Benign0.01Affected-3-35.416.04
c.2825C>TP942LLikely BenignUncertain 16-33443377-C-T42.48e-6-5.063Likely Benign0.086Likely BenignLikely Benign0.048Likely Benign-2.00Neutral0.411Benign0.239Benign2.37Pathogenic0.00Affected4.324-3-35.416.04
c.3194C>TP1065LLikely Benign 16-33443746-C-T148.71e-6-5.085Likely Benign0.089Likely BenignLikely Benign0.068Likely Benign-2.94Deleterious0.950Possibly Damaging0.419Benign2.01Pathogenic0.00Affected4.322-3-35.416.04
c.3197C>TP1066LLikely BenignLikely Benign 16-33443749-C-T148.71e-6-5.478Likely Benign0.092Likely BenignLikely Benign0.173Likely Benign-3.68Deleterious0.996Probably Damaging0.903Possibly Damaging2.72Benign0.00Affected4.322-3-35.416.04
c.3290C>TP1097LLikely BenignBenign 1-4.410Likely Benign0.145Likely BenignLikely Benign0.131Likely Benign-2.07Neutral0.611Possibly Damaging0.198Benign2.64Benign0.05Affected3.775-3-35.416.04
c.3848C>TP1283LLikely BenignBenign 16-33447896-C-T322.06e-5-3.740Likely Benign0.093Likely BenignLikely Benign0.047Likely Benign-1.04Neutral0.005Benign0.003Benign2.76Benign0.06Tolerated3.775-3-35.416.04
c.3860C>TP1287LLikely BenignConflicting 26-33447908-C-T-2.800Likely Benign0.117Likely BenignLikely Benign0.061Likely Benign-1.66Neutral0.021Benign0.017Benign2.76Benign0.02Affected3.775-3-35.416.04
c.3920C>TP1307LLikely BenignBenign 16-33451794-C-T116.82e-6-4.044Likely Benign0.144Likely BenignLikely Benign0.292Likely Benign-1.49Neutral0.779Possibly Damaging0.220Benign2.82Benign0.04Affected3.775-3-35.416.04
c.3941C>TP1314LLikely BenignLikely Benign 16-33451815-C-T21.24e-6-4.040Likely Benign0.118Likely BenignLikely Benign0.049Likely Benign-0.20Neutral0.421Benign0.066Benign4.19Benign0.05Affected3.775-3-35.416.04
c.3974C>TP1325LLikely BenignUncertain 16-33451848-C-T-5.256Likely Benign0.085Likely BenignLikely Benign0.146Likely Benign-1.05Neutral0.000Benign0.000Benign4.05Benign0.00Affected4.321-3-35.416.04
c.3977C>TP1326LLikely BenignUncertain 1-5.541Likely Benign0.115Likely BenignLikely Benign0.117Likely Benign-1.06Neutral0.999Probably Damaging0.994Probably Damaging3.62Benign0.00Affected3.775-3-35.416.04
c.3980C>TP1327LLikely BenignUncertain 16-33451854-C-T21.28e-6-5.264Likely Benign0.242Likely BenignLikely Benign0.142Likely Benign-1.24Neutral0.994Probably Damaging0.908Possibly Damaging4.12Benign0.10Tolerated3.775-3-35.416.04
c.59C>TP20LLikely BenignUncertain 3-3.289Likely Benign0.464AmbiguousLikely Benign0.100Likely Benign-0.44Neutral0.909Possibly Damaging0.713Possibly Damaging4.27Benign0.00Affected4.321-3-35.416.04
c.953C>TP318L
(3D Viewer)
Likely PathogenicC2Uncertain 36-33437858-C-T31.86e-6-10.090Likely Pathogenic0.958Likely PathogenicLikely Pathogenic0.624Likely Pathogenic1.33Ambiguous0.10.26Likely Benign0.80Ambiguous0.43Likely Benign-8.96Deleterious1.000Probably Damaging0.999Probably Damaging1.82Pathogenic0.03Affected3.3823-3-35.416.04228.6-68.9-0.70.7-0.40.1XPotentially BenignThe cyclic five-membered pyrrolidine ring of Pro318, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Asp330-Ala322, res. Thr305-Asn315), packs against the hydrophobic side chain of Ile205 at the end of the anti-parallel β sheet in the PH domain. In the variant simulations, the iso-butyl side chain of Leu318 is unable to do the same, potentially weakening the PH and C2 domain association. Importantly, the residue swap could also affect loop formation during folding, as proline can make tighter turns than leucine. Because the residue swap could affect the C2 domain stability, it could also negatively impact the SynGAP-membrane association.
c.2029A>TS677C
(3D Viewer)
Likely BenignGAPBenign 1-8.496Likely Pathogenic0.076Likely BenignLikely Benign0.153Likely Benign-0.51Ambiguous0.3-0.30Likely Benign-0.41Likely Benign0.15Likely Benign-2.41Neutral0.932Possibly Damaging0.222Benign3.25Benign0.04Affected3.4123-103.316.06
c.227C>GS76CLikely BenignUncertain 16-33425835-C-G21.24e-6-5.408Likely Benign0.100Likely BenignLikely Benign0.076Likely Benign-1.78Neutral0.992Probably Damaging0.869Possibly Damaging3.71Benign0.00Affected4.3210-13.316.06
c.2339C>GS780CLikely BenignUncertain 46-33442891-C-G169.94e-6-7.603In-Between0.278Likely BenignLikely Benign0.078Likely Benign-1.41Neutral0.065Benign0.043Benign2.59Benign0.10Tolerated3.646-103.316.06
c.2518A>TS840CLikely PathogenicUncertain 1-8.799Likely Pathogenic0.904Likely PathogenicAmbiguous0.376Likely Benign-3.96Deleterious0.999Probably Damaging0.975Probably Damaging1.50Pathogenic0.00Affected3.7750-13.316.06
c.2719A>TS907CLikely BenignLikely Benign 1-6.685Likely Benign0.298Likely BenignLikely Benign0.113Likely Benign-2.34Neutral0.999Probably Damaging0.988Probably Damaging2.60Benign0.02Affected3.7750-13.316.06
c.3038C>GS1013CLikely BenignUncertain 16-33443590-C-G42.48e-6-6.745Likely Benign0.110Likely BenignLikely Benign0.058Likely Benign-2.06Neutral0.898Possibly Damaging0.579Possibly Damaging2.64Benign0.05Affected3.7750-13.316.06
c.611C>GS204C
(3D Viewer)
Likely BenignPHUncertain 1-6.613Likely Benign0.127Likely BenignLikely Benign0.148Likely Benign0.65Ambiguous0.4-1.13Ambiguous-0.24Likely Benign0.10Likely Benign-0.64Neutral0.978Probably Damaging0.753Possibly Damaging4.13Benign0.05Affected3.44100-13.316.06223.6-13.80.60.30.00.2XUncertainThe hydroxyl-containing Ser204, located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by the thiol-containing cysteine. In the WT simulations, Ser204 simultaneously forms hydrogen bonds with the backbone carbonyl of Asp201 and the hydroxyl group of Thr224, helping to stabilize the two anti-parallel β strands (res. Ile205-Lys207 and Cys219-Thr223) at the end of the β sheet. Since the thiol group of cysteine forms weaker hydrogen bonds than the hydroxyl group of serine, Cys204 does not maintain the hydrogen bond network as stably as Ser204 in the variant simulations. However, because the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.1651C>AL551M
(3D Viewer)
GAPUncertain 16-33438894-C-A74.34e-6-9.937Likely Pathogenic0.480AmbiguousLikely Benign0.544Likely Pathogenic-0.07Likely Benign0.10.13Likely Benign0.03Likely Benign0.71Ambiguous-0.56Neutral1.000Probably Damaging1.000Probably Damaging-1.48Pathogenic0.06Tolerated3.373542-1.918.03246.5-18.60.00.00.30.0XPotentially BenignL551 is located on an α-helix (res. Ala533-Val560). The iso-butyl side chain of Leu551 hydrophobically packs with nearby hydrophobic residues such as Cys547, Phe652, Leu633, and Ile630 in the inter-helix space. In the variant simulations, the thioether side chain of Met551 can maintain similar hydrophobic interactions as Leu551 in the WT, thus causing no negative effect on the protein structure during the simulations.
c.1752C>GI584M
(3D Viewer)
Likely PathogenicGAPUncertain 26-33440804-C-G16.20e-7-10.119Likely Pathogenic0.419AmbiguousLikely Benign0.478Likely Benign0.11Likely Benign0.10.46Likely Benign0.29Likely Benign1.16Destabilizing-2.62Deleterious0.983Probably Damaging0.925Probably Damaging-1.25Pathogenic0.12Tolerated3.373421-2.618.03247.5-20.3-0.10.3-0.10.1XPotentially BenignA hydrophobic residue, Ile584, located in an α helix (res. Glu582-Met603), is swapped for another hydrophobic residue, Met584. The sec-butyl hydrocarbon side chain of Ile584 packs hydrophobically with residues in an inter-helix hydrophobic space (e.g., Leu588, Met477, Val473, and Ile483).In the variant simulations, the thioether hydrophobic side chain of Met584 maintains similar interactions as Ile584 in the WT, as it is roughly the same size and fits well within the hydrophobic space. Thus, the residue swap does not appear to cause any negative effects on the protein structure.
c.1767C>GI589M
(3D Viewer)
Likely PathogenicGAPUncertain 1-12.225Likely Pathogenic0.926Likely PathogenicAmbiguous0.830Likely Pathogenic0.74Ambiguous0.21.54Ambiguous1.14Ambiguous1.33Destabilizing-2.99Deleterious1.000Probably Damaging1.000Probably Damaging-1.94Pathogenic0.00Affected3.373521-2.618.03267.6-24.50.00.0-0.10.1XPotentially BenignA hydrophobic residue, Ile589, located in an α helix (res. Glu582-Met603), is swapped for another hydrophobic residue, methionine. The sec-butyl hydrocarbon side chain of Ile589 packs favourably with multiple residues in the inter-helix hydrophobic space (e.g., Phe569, Ile667, and Leu664).Although the S-methyl thioether group of the Met589 side chain in the variant is longer than the branched side chain of isoleucine, it stacks favourably with the aromatic phenol ring. Additionally, the polar sulphur atom forms a weak hydrogen bond with the guanidinium group of Arg573, which in turn forms a salt bridge with the carboxylate group of Asp586.Overall, the hydrophobic packing in the inter-helix space does not appear to be disrupted in the variant simulations.
c.2503C>AL835MLikely BenignBenign 1-4.153Likely Benign0.121Likely BenignLikely Benign0.068Likely Benign-0.45Neutral0.999Probably Damaging0.977Probably Damaging2.67Benign0.12Tolerated3.77524-1.918.03
c.3721C>AL1241MCoiled-coilUncertain 1-5.881Likely Benign0.782Likely PathogenicLikely Benign0.167Likely Benign-1.43Neutral1.000Probably Damaging0.999Probably Damaging1.65Pathogenic0.00Affected42-1.918.03
c.1673A>GH558R
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.445Likely Pathogenic0.554AmbiguousLikely Benign0.587Likely Pathogenic-1.14Ambiguous0.1-0.23Likely Benign-0.69Ambiguous1.03Destabilizing-4.94Deleterious0.677Possibly Damaging0.239Benign-1.24Pathogenic0.14Tolerated3.373502-1.319.05
c.194A>GH65RLikely BenignUncertain 16-33425802-A-G16.20e-7-1.980Likely Benign0.967Likely PathogenicLikely Pathogenic0.073Likely Benign-1.60Neutral0.462Possibly Damaging0.227Benign4.19Benign0.00Affected4.32120-1.319.05
c.2852A>GH951RLikely BenignLikely Pathogenic 1-4.964Likely Benign0.125Likely BenignLikely Benign0.185Likely Benign-1.08Neutral0.048Benign0.029Benign5.46Benign0.24Tolerated3.77520-1.319.05
c.2888A>GH963RLikely BenignUncertain 16-33443440-A-G84.96e-6-8.952Likely Pathogenic0.169Likely BenignLikely Benign0.081Likely Benign-1.28Neutral0.001Benign0.003Benign4.15Benign0.24Tolerated3.77520-1.319.05
c.2050G>CD684H
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.194Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.613Likely Pathogenic3.36Destabilizing1.02.95Destabilizing3.16Destabilizing0.55Ambiguous-6.98Deleterious1.000Probably Damaging0.972Probably Damaging3.36Benign0.00Affected3.4217-110.322.05
c.2809G>CD937HLikely BenignUncertain 1-0.733Likely Benign0.677Likely PathogenicLikely Benign0.150Likely Benign-1.74Neutral1.000Probably Damaging0.975Probably Damaging2.68Benign0.13Tolerated3.775-110.322.05
c.451G>CD151HLikely PathogenicUncertain 16-33432748-G-C21.26e-6-11.747Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.335Likely Benign-3.90Deleterious0.999Probably Damaging0.995Probably Damaging3.86Benign0.00Affected3.615-110.322.05
c.859G>CD287H
(3D Viewer)
Likely PathogenicC2Likely Pathogenic 1-14.518Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.589Likely Pathogenic0.48Likely Benign0.30.32Likely Benign0.40Likely Benign0.63Ambiguous-6.43Deleterious1.000Probably Damaging0.999Probably Damaging1.51Pathogenic0.00Affected3.38231-10.322.05235.63.80.11.20.10.1XXPotentially PathogenicThe carboxylate group of Asp287, located at the beginning of a β hairpin loop connecting two anti-parallel β sheet strands (res. Arg279-Leu286, res. Met289-Pro298), maintains a salt bridge with the guanidinium group of Arg324 in the β sheet during the WT simulations. In the variant simulations, the imidazole ring of the His287 side chain is unable to form a salt bridge with Arg324 or establish any other stable compensatory interactions, which could weaken the beta sandwich assembly of the C2 domain. This destabilization of the C2 domain could adversely affect the stability of the SynGAP-membrane association.
c.1763T>AL588H
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-16.947Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.939Likely Pathogenic4.20Destabilizing0.23.69Destabilizing3.95Destabilizing2.26Destabilizing-6.97Deleterious1.000Probably Damaging1.000Probably Damaging-1.42Pathogenic0.00Affected3.3834-2-3-7.023.98214.320.90.00.00.00.2XXXPotentially PathogenicThe isobutyl group of the Leu588 side chain, located in an α helix (res. Glu582-Met603), packs against hydrophobic residues in the inter-helix hydrophobic space (e.g., Ile584, Trp572, Phe484, Met470, Val473, Ile483).In the variant simulations, the imidazole ring of His588 is aromatic but contains polar delta and epsilon nitrogen atoms that are not suited for the hydrophobic niche. The protonated epsilon nitrogen forms a hydrogen bond with the backbone carbonyl group of Ala469, which can disrupt the continuity of the opposing α helix (res. Phe476-Lys460).While the residue swap could affect the tertiary assembly and the underlying protein folding process, it is difficult to determine if the mutation would be tolerated based solely on the variant simulations.
c.1778T>AL593H
(3D Viewer)
Likely PathogenicGAPUncertain 1-16.504Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.812Likely Pathogenic2.52Destabilizing0.22.32Destabilizing2.42Destabilizing2.75Destabilizing-6.77Deleterious1.000Probably Damaging1.000Probably Damaging2.77Benign0.00Affected3.3735-2-3-7.023.98222.020.70.00.00.20.0XXPotentially PathogenicThe iso-propyl side chain of Leu593, located in an α helix (res. Glu582-Met603), packs favourably with multiple hydrophobic residues in the inter-helix space (e.g., Leu598, Ile589, Phe594, Phe561).In the variant simulations, His593 retains a similar packing arrangement via its aromatic imidazole ring. However, the polar nitrogen atoms introduce hydrogen bond donors and acceptors into the previously hydrophobic space. The epsilon protonated nitrogen of His593 forms a stable hydrogen bond with the phenol group of the Tyr505 side chain in an α helix (res. Gln503-Tyr518).While the residue swap could affect the tertiary assembly and the underlying protein folding process, it is difficult to determine if the mutation would be tolerated based solely on the variant simulations.
c.1493T>GM498R
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-8.812Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.869Likely Pathogenic3.85Destabilizing0.22.35Destabilizing3.10Destabilizing1.76Destabilizing-4.53Deleterious0.464Possibly Damaging0.120Benign-1.36Pathogenic0.00Affected0-1-6.424.99
c.106C>TH36YLikely BenignUncertain 16-33423515-C-T21.24e-6-3.461Likely Benign0.139Likely BenignLikely Benign0.023Likely Benign-1.03Neutral0.219Benign0.066Benign4.16Benign0.00Affected4.321021.926.03
c.1441C>TH481Y
(3D Viewer)
Likely PathogenicGAPLikely Benign 16-33438473-C-T169.91e-6-10.910Likely Pathogenic0.565Likely PathogenicLikely Benign0.256Likely Benign-0.53Ambiguous0.1-0.46Likely Benign-0.50Ambiguous0.20Likely Benign-3.32Deleterious0.988Probably Damaging0.979Probably Damaging3.40Benign0.59Tolerated3.3733021.926.03256.5-44.40.00.00.20.2XXUncertainThe imidazole ring of the His481 side chain is located in a short helical structure (res. Glu480-Leu482) within an α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. In the WT simulations, His481 alternately stacks against Arg485, Arg587, and Glu480 without a definite role. In the variant simulations, Tyr481 also alternately stacks with nearby arginine residues, including Arg485, Arg587, and Arg479. The interaction between Tyr481 and Arg479 affects the α-α loop, causing it to fold into a distorted helical structure, an effect that might be more pronounced during protein folding. Finally, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.2881C>TH961YLikely BenignConflicting 26-33443433-C-T31.86e-6-8.051Likely Pathogenic0.157Likely BenignLikely Benign0.102Likely Benign-1.07Neutral0.716Possibly Damaging0.147Benign4.10Benign0.55Tolerated3.775021.926.03
c.3607C>TH1203YLikely BenignCoiled-coilUncertain 16-33446599-C-T21.24e-6-6.834Likely Benign0.149Likely BenignLikely Benign0.233Likely Benign-1.52Neutral0.006Benign0.011Benign5.55Benign0.10Tolerated3.775201.926.03
c.502C>TH168YLikely BenignBenign 1-8.914Likely Pathogenic0.264Likely BenignLikely Benign0.065Likely Benign-1.53Neutral0.192Benign0.062Benign4.18Benign0.01Affected4.323021.926.03
c.88C>TH30YLikely BenignUncertain 1-3.047Likely Benign0.115Likely BenignLikely Benign0.082Likely Benign-1.84Neutral0.273Benign0.478Possibly Damaging3.99Benign0.00Affected4.321021.926.03
c.1468G>CA490P
(3D Viewer)
Likely PathogenicGAPUncertain 1-12.905Likely Pathogenic0.941Likely PathogenicAmbiguous0.878Likely Pathogenic-1.27Ambiguous0.11.31Ambiguous0.02Likely Benign1.07Destabilizing-4.81Deleterious1.000Probably Damaging0.998Probably Damaging-1.42Pathogenic0.01Affected3.3735-11-3.426.04
c.1621G>CA541P
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.733Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.594Likely Pathogenic2.47Destabilizing0.37.26Destabilizing4.87Destabilizing0.86Ambiguous-3.16Deleterious1.000Probably Damaging0.998Probably Damaging-1.34Pathogenic0.07Tolerated3.37351-1-3.426.04170.4-11.20.10.00.10.0XPotentially PathogenicAla541 is located on the outer surface of an α-helix (res. Ala533-Val560). The methyl group of Ala541 is on the surface and does not form any interactions. Proline lacks a free backbone amide group, and thus, Pro541 is unable to form a hydrogen bond with the carbonyl group of Ala537 in the variant simulations. Consequently, Pro541 disrupts the continuity of the secondary structure element, causing the α-helix to bend slightly in the variant simulations.
c.1771G>CA591P
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.479Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.404Likely Benign3.78Destabilizing0.37.29Destabilizing5.54Destabilizing1.45Destabilizing-4.41Deleterious0.995Probably Damaging0.853Possibly Damaging3.35Benign0.01Affected3.37351-1-3.426.04191.5-10.10.20.10.40.1XPotentially PathogenicThe methyl group of the Ala591 side chain, located in the middle of an α helix (res. Glu582-Met603), packs against hydrophobic residues (e.g., Ile483, Phe484) of an opposing partially helical loop (res. Phe476-Asn487).In the variant simulations, Pro591 lacks a free backbone amide group and, therefore, cannot form a hydrogen bond with the backbone carbonyl of Arg587 as Ala591 does in the WT. This notably weakens the α helix integrity and compromises the continuity of the helix. In reality, the effect on the structure during protein folding could be more severe.
c.3304G>CA1102PLikely BenignUncertain 1-5.120Likely Benign0.077Likely BenignLikely Benign0.118Likely Benign-0.97Neutral0.000Benign0.002Benign2.26Pathogenic0.13Tolerated3.775-11-3.426.04
c.3964G>CA1322PLikely BenignBenign 16-33451838-G-C-1.153Likely Benign0.063Likely BenignLikely Benign0.090Likely Benign0.03Neutral0.000Benign0.000Benign4.15Benign0.23Tolerated3.7751-1-3.426.04
c.43G>CA15PLikely BenignUncertain 1-3.436Likely Benign0.097Likely BenignLikely Benign0.146Likely Benign-0.23Neutral0.880Possibly Damaging0.123Benign4.09Benign0.00Affected1-1-3.426.04
c.583G>CA195PLikely PathogenicLikely Pathogenic 1-9.715Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.152Likely Benign-3.03Deleterious0.997Probably Damaging0.916Probably Damaging4.00Benign0.04Affected3.5461-1-3.426.04
c.1136C>TS379L
(3D Viewer)
Likely BenignC2Benign 16-33438041-C-T84.05e-5-5.641Likely Benign0.173Likely BenignLikely Benign0.469Likely Benign0.39Likely Benign0.23.38Destabilizing1.89Ambiguous-0.52Ambiguous-0.85Neutral0.015Benign0.002Benign3.83Benign0.04Affected4.3211-3-24.626.08251.9-48.10.61.10.00.5UncertainSer379 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like leucine are rarely tolerated. Although no negative structural effects are observed in the variant simulations, Leu379 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effect on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1154C>TS385L
(3D Viewer)
Likely BenignC2Uncertain 26-33438059-C-T94.60e-5-6.018Likely Benign0.167Likely BenignLikely Benign0.304Likely Benign0.16Likely Benign0.10.08Likely Benign0.12Likely Benign-0.26Likely Benign-0.68Neutral0.829Possibly Damaging0.706Possibly Damaging4.63Benign0.01Affected4.323-3-24.626.08244.6-50.10.00.6-0.10.1UncertainSer385 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like leucine are rarely tolerated. Although no negative structural effects are observed in the variant simulations, Leu385 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effects on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.155C>TS52LUncertain 16-33423564-C-T16.20e-7-7.199In-Between0.688Likely PathogenicLikely Benign0.087Likely Benign-1.41Neutral0.829Possibly Damaging0.706Possibly Damaging4.10Benign0.00Affected4.321-3-24.626.08
c.1712C>TS571L
(3D Viewer)
Likely PathogenicGAPUncertain 16-33440764-C-T16.23e-7-11.651Likely Pathogenic0.660Likely PathogenicLikely Benign0.841Likely Pathogenic-1.53Ambiguous0.1-1.05Ambiguous-1.29Ambiguous0.27Likely Benign-5.61Deleterious1.000Probably Damaging0.996Probably Damaging-1.25Pathogenic0.04Affected3.3735-2-34.626.08
c.2255C>TS752LLikely BenignUncertain 26-33441720-C-T63.72e-6-3.386Likely Benign0.182Likely BenignLikely Benign0.195Likely Benign-2.09Neutral0.993Probably Damaging0.641Possibly Damaging1.51Pathogenic0.01Affected3.995-3-24.626.08
c.1811C>TS604L
(3D Viewer)
Likely PathogenicGAPUncertain 16-33440863-C-T63.72e-6-14.683Likely Pathogenic0.965Likely PathogenicLikely Pathogenic0.639Likely Pathogenic-0.94Ambiguous0.1-1.24Ambiguous-1.09Ambiguous-0.31Likely Benign-5.97Deleterious1.000Probably Damaging0.991Probably Damaging3.09Benign0.00Affected3.3735-3-24.626.08234.0-49.60.00.10.30.5XXPotentially PathogenicSer604 is located in a short turn between an α helix (res. Glu582-Met603) and a short α helical section (res. Ser606-Phe608). In the WT simulations, the hydroxyl side chain of Ser604 periodically hydrogen bonds with the backbone carbonyl groups of other α helix residues (e.g., Pro600, Met603). Serine weakens the α helix secondary structure, and thus, Ser604 along with Pro605 breaks the α helix, facilitating the turn in the WT structure.In contrast, in the variant simulations, Leu604 forms a few hydrophobic interactions (e.g., Leu607, Phe608). More importantly, the helix end is more stable than with Ser604 in the WT. The residue swap could have a more profound effect on the actual folding process, for example, by preventing the bending at the α helix end, than what the simulations suggest.Moreover, Ser604 directly hydrogen bonds with Ras residues Ser65 and Ala66 in the WT SynGAP-Ras complex. The hydrophobic leucine cannot maintain these interactions with Ras at the GAP-Ras interface. Thus, the effect of the residue swap on the complex formation with the GTPase cannot be fully explored in the solvent-only simulations.
c.2474C>TS825LLikely PathogenicUncertain 16-33443026-C-T16.20e-7-4.987Likely Benign0.910Likely PathogenicAmbiguous0.249Likely Benign-4.30Deleterious0.999Probably Damaging0.994Probably Damaging1.94Pathogenic0.01Affected3.775-2-34.626.08
c.2582C>TS861LLikely BenignUncertain 16-33443134-C-T21.24e-6-4.966Likely Benign0.219Likely BenignLikely Benign0.144Likely Benign-2.10Neutral0.904Possibly Damaging0.355Benign3.93Benign0.07Tolerated4.323-3-24.626.08
c.2627C>TS876LUncertain 2-5.856Likely Benign0.489AmbiguousLikely Benign0.249Likely Benign-3.56Deleterious0.998Probably Damaging0.992Probably Damaging2.57Benign0.05Affected3.775-2-34.626.08
c.2690C>TS897LLikely BenignUncertain 1-4.034Likely Benign0.299Likely BenignLikely Benign0.028Likely Benign-1.71Neutral0.901Possibly Damaging0.636Possibly Damaging2.66Benign0.01Affected-3-24.626.08
c.314C>TS105LLikely BenignUncertain 26-33432179-C-T42.48e-6-3.710Likely Benign0.233Likely BenignLikely Benign0.095Likely Benign-1.52Neutral0.828Possibly Damaging0.048Benign4.06Benign0.00Affected4.321-3-24.626.08
c.3323G>TS1108IUncertain 16-33443875-G-T-3.666Likely Benign0.292Likely BenignLikely Benign0.145Likely Benign-3.73Deleterious0.971Probably Damaging0.604Possibly Damaging2.44Pathogenic0.10Tolerated3.775-2-15.326.08
c.3494C>TS1165LLikely BenignConflicting 2-2.984Likely Benign0.793Likely PathogenicAmbiguous0.166Likely Benign-2.01Neutral0.998Probably Damaging0.992Probably Damaging2.60Benign0.33Tolerated3.883-3-24.626.0810.1016/j.ajhg.2020.11.011
c.3557C>TS1186LCoiled-coilUncertain 16-33444592-C-T-4.829Likely Benign0.923Likely PathogenicAmbiguous0.177Likely Benign-2.58Deleterious0.998Probably Damaging0.992Probably Damaging2.65Benign0.04Affected3.824-3-24.626.08
c.1370G>AS457NLikely PathogenicGAPUncertain 1-10.221Likely Pathogenic0.949Likely PathogenicAmbiguous0.241Likely Benign0.19Likely Benign0.0-0.22Likely Benign-0.02Likely Benign0.67Ambiguous-2.76Deleterious0.940Possibly Damaging0.843Possibly Damaging3.28Benign0.06Tolerated11-2.727.03
c.221G>AS74NLikely BenignUncertain 16-33425829-G-A53.10e-6-5.156Likely Benign0.112Likely BenignLikely Benign0.031Likely Benign-0.89Neutral0.043Benign0.007Benign4.09Benign0.00Affected4.32111-2.727.03
c.2294G>AS765NLikely BenignUncertain 1-5.098Likely Benign0.378AmbiguousLikely Benign0.094Likely Benign-0.94Neutral0.985Probably Damaging0.950Probably Damaging4.11Benign0.06Tolerated3.64611-2.727.03
c.2573G>AS858NLikely BenignUncertain 16-33443125-G-A21.24e-6-4.311Likely Benign0.121Likely BenignLikely Benign0.107Likely Benign-0.67Neutral0.448Benign0.846Possibly Damaging4.13Benign0.02Affected3.77511-2.727.03
c.2111G>AS704N
(3D Viewer)
Likely BenignGAPBenign/Likely benign 36-33441370-G-A271.67e-5-5.917Likely Benign0.421AmbiguousLikely Benign0.058Likely Benign0.48Likely Benign0.1-0.12Likely Benign0.18Likely Benign0.54Ambiguous-0.49Neutral0.771Possibly Damaging0.275Benign3.39Benign0.08Tolerated3.471011-2.727.03233.2-29.1-0.10.0-0.10.1XPotentially BenignSer704 is located at the end and outer surface of an α-helix (res. Thr704-Gly712), which is connected via a tight turn or loop to another α-helix (res. Asp684-Gln702). The hydroxyl side chain of Ser704 occasionally forms a hydrogen bond with the amide group of Ala707. However, in the variant simulations, the carboxamide side chain of Asn704 achieves more lasting and numerous hydrogen-bonding interactions with the residues at the helix end, such as Glu706, Ala707, and Leu708. Consequently, the residue swap could strengthen the α-helix secondary structure integrity at the helix end, which could have either positive or negative effects on its function.
c.2684G>AS895NLikely BenignUncertain 1-6.399Likely Benign0.604Likely PathogenicLikely Benign0.118Likely Benign-0.85Neutral0.991Probably Damaging0.988Probably Damaging2.64Benign0.30Tolerated4.32411-2.727.03
c.2948G>AS983NLikely Benign 16-33443500-G-A63.72e-6-5.604Likely Benign0.909Likely PathogenicAmbiguous0.136Likely Benign-1.78Neutral0.991Probably Damaging0.988Probably Damaging2.04Pathogenic0.00Affected4.32111-2.727.03
c.2954G>AS985NLikely BenignUncertain 1-6.979Likely Benign0.845Likely PathogenicAmbiguous0.088Likely Benign-1.68Neutral0.991Probably Damaging0.988Probably Damaging2.65Benign0.00Affected4.32111-2.727.03
c.3020G>AS1007NLikely BenignBenign 1-5.113Likely Benign0.803Likely PathogenicAmbiguous0.075Likely Benign-1.54Neutral0.997Probably Damaging0.992Probably Damaging2.65Benign0.01Affected3.77511-2.727.03
c.3170G>AS1057NLikely BenignUncertain 1-6.386Likely Benign0.117Likely BenignLikely Benign0.218Likely Benign-0.41Neutral0.451Benign0.129Benign5.25Benign0.28Tolerated11-2.727.03
c.3293G>AS1098NLikely BenignConflicting 26-33443845-G-A63.89e-6-5.120Likely Benign0.156Likely BenignLikely Benign0.063Likely Benign-0.58Neutral0.369Benign0.120Benign2.76Benign0.36Tolerated3.77511-2.727.03
c.3731G>AS1244NLikely PathogenicCoiled-coilUncertain 1-9.008Likely Pathogenic0.751Likely PathogenicLikely Benign0.154Likely Benign-1.87Neutral0.997Probably Damaging0.992Probably Damaging2.10Pathogenic0.15Tolerated3.77511-2.727.03
c.401G>AS134NLikely BenignUncertain 1-5.534Likely Benign0.813Likely PathogenicAmbiguous0.075Likely Benign-1.62Neutral0.001Benign0.002Benign3.90Benign0.00Affected3.61511-2.727.03
c.416G>AS139NLikely BenignUncertain 16-33432713-G-A32.22e-6-4.584Likely Benign0.688Likely PathogenicLikely Benign0.109Likely Benign-0.75Neutral0.149Benign0.047Benign4.14Benign0.24Tolerated3.61511-2.727.03
c.5G>AS2NLikely BenignUncertain 26-33420269-G-A31.96e-6-4.104Likely Benign0.207Likely BenignLikely Benign0.092Likely Benign-0.36Neutral0.000Benign0.000Benign4.06Benign0.00Affected4.32111-2.727.03
c.2015C>AT672K
(3D Viewer)
Likely PathogenicGAPUncertain 1-12.192Likely Pathogenic0.698Likely PathogenicLikely Benign0.065Likely Benign0.20Likely Benign0.51.21Ambiguous0.71Ambiguous0.72Ambiguous-4.31Deleterious0.745Possibly Damaging0.051Benign3.40Benign0.07Tolerated3.40250-1-3.227.07195.17.00.40.70.40.1XXPotentially PathogenicThe hydroxyl group of Thr672, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop itself, such as Lys566, Glu666, and Asn669. In the variant simulations, Lys672 can only form a hydrogen bond with the amino group of the Lys566 side chain via its backbone carbonyl group. Consequently, it cannot maintain the Lys566-Glu666 salt bridge through hydrogen bonding. However, the amino group of Lys periodically forms a salt bridge with the carboxylate group of Glu666, which prevents a drastic disruption of the hydrogen-bond network that keeps the loop close to the helices.
c.1511A>GK504R
(3D Viewer)
Likely BenignGAPUncertain16-33438543-A-G21.24e-6-4.365Likely Benign0.088Likely BenignLikely Benign0.238Likely Benign0.13Likely Benign0.10.51Ambiguous0.32Likely Benign0.94Ambiguous-2.16Neutral0.002Benign0.015Benign-1.41Pathogenic0.11Tolerated3.373523-0.628.01
c.1913A>GK638R
(3D Viewer)
Likely BenignGAPUncertain 1-2.700Likely Benign0.110Likely BenignLikely Benign0.216Likely Benign0.09Likely Benign0.1-0.04Likely Benign0.03Likely Benign0.53Ambiguous-2.55Deleterious0.649Possibly Damaging0.240Benign3.41Benign0.13Tolerated3.373123-0.628.01
c.2408A>GK803RLikely BenignSH3-binding motifUncertain 1-2.281Likely Benign0.097Likely BenignLikely Benign0.018Likely Benign-1.52Neutral0.103Benign0.038Benign2.38Pathogenic0.00Affected3.77532-0.628.01
c.323A>GK108RLikely BenignUncertain 16-33432188-A-G63.72e-6-2.892Likely Benign0.148Likely BenignLikely Benign0.184Likely Benign0.37Neutral0.993Probably Damaging0.956Probably Damaging4.22Benign1.00Tolerated3.61532-0.628.01
c.1610C>TA537V
(3D Viewer)
Likely BenignGAPLikely Benign 16-33438853-C-T74.34e-6-6.888Likely Benign0.120Likely BenignLikely Benign0.382Likely Benign0.54Ambiguous0.0-0.05Likely Benign0.25Likely Benign0.41Likely Benign-1.97Neutral0.977Probably Damaging0.469Possibly Damaging-1.26Pathogenic0.24Tolerated3.3735002.428.05220.3-45.10.00.0-0.70.1XPotentially BenignAla537 is located on the outer surface of an α-helix (res. Ala533-Val560). The methyl group of Ala537 is on the surface and does not form any interactions. In the variant simulations, the iso-propyl side chain of Val537 is also on the surface, similar to Ala537 in the WT, causing no negative structural effects.
c.1802C>TA601V
(3D Viewer)
Likely PathogenicGAPUncertain 1-10.447Likely Pathogenic0.853Likely PathogenicAmbiguous0.535Likely Pathogenic1.64Ambiguous0.10.35Likely Benign1.00Ambiguous0.81Ambiguous-3.98Deleterious1.000Probably Damaging0.989Probably Damaging2.74Benign0.03Affected3.3735002.428.05228.5-45.50.00.00.40.5XPotentially BenignThe methyl side chain of Ala601, located on an α helix (res. Glu582-Met603), packs hydrophobically against other hydrophobic residues in the inter-helix space (e.g., Phe597, Leu598, Leu506, Phe608).In the variant simulations, Val601, which has similar size and physicochemical properties to alanine, resides in the inter-helix hydrophobic space in a similar manner to Ala601 in the WT, causing no apparent negative effect on the protein structure. However, the effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.2591C>TA864VLikely BenignUncertain 26-33443143-C-T63.72e-6-4.749Likely Benign0.126Likely BenignLikely Benign0.038Likely Benign-1.35Neutral0.767Possibly Damaging0.119Benign2.45Pathogenic0.30Tolerated3.824002.428.05
c.2657C>TA886VLikely BenignUncertain 16-33443209-C-T181.12e-5-4.478Likely Benign0.078Likely BenignLikely Benign0.061Likely Benign-0.20Neutral0.888Possibly Damaging0.314Benign2.17Pathogenic0.00Affected4.324002.428.05
c.2702C>TA901VLikely BenignUncertain 26-33443254-C-T21.24e-6-5.043Likely Benign0.219Likely BenignLikely Benign0.029Likely Benign-1.83Neutral0.106Benign0.009Benign2.64Benign0.17Tolerated3.775002.428.05
c.2753C>TA918VLikely BenignUncertain 36-33443305-C-T21.24e-6-3.684Likely Benign0.112Likely BenignLikely Benign0.119Likely Benign-1.61Neutral0.980Probably Damaging0.782Possibly Damaging2.61Benign0.03Affected4.324002.428.05
c.3305C>TA1102VLikely BenignBenign 16-33443857-C-T-2.440Likely Benign0.077Likely BenignLikely Benign0.081Likely Benign-1.27Neutral0.017Benign0.028Benign2.29Pathogenic0.12Tolerated3.775002.428.05
c.3449C>TA1150VLikely BenignUncertain 16-33444484-C-T31.86e-6-3.648Likely Benign0.192Likely BenignLikely Benign0.066Likely Benign-2.22Neutral0.114Benign0.055Benign2.32Pathogenic0.04Affected3.775002.428.05
c.371C>TA124VLikely BenignConflicting 26-33432236-C-T95.58e-6-4.259Likely Benign0.138Likely BenignLikely Benign0.073Likely Benign-1.52Neutral0.173Benign0.009Benign4.07Benign0.03Affected3.615002.428.05
c.44C>TA15VLikely BenignUncertain 16-33420308-C-T16.49e-7-3.560Likely Benign0.161Likely BenignLikely Benign0.105Likely Benign0.20Neutral0.602Possibly Damaging0.015Benign4.19Benign0.00Affected4.321002.428.05
c.707C>TA236V
(3D Viewer)
PHBenign/Likely benign 26-33435558-C-T63.72e-6-8.752Likely Pathogenic0.267Likely BenignLikely Benign0.777Likely Pathogenic0.61Ambiguous0.21.08Ambiguous0.85Ambiguous0.64Ambiguous-3.55Deleterious0.981Probably Damaging0.446Benign5.79Benign0.03Affected3.4014002.428.05213.8-44.70.00.0-0.20.2XPotentially BenignThe methyl side chain of Ala236, located on an α helix (residues Ala236-Val250) facing an anti-parallel β sheet strand (residues Ile205-Val209), interacts hydrophobically with nearby residues such as Arg239 and Phe218. In the variant simulations, the isopropyl branched hydrocarbon side chain of Val236 maintains similar hydrophobic interactions as alanine in the WT, with an overall arrangement remarkably similar to Ala236. The residue swap does not affect the protein structure based on the simulations.
c.2105A>GQ702R
(3D Viewer)
GAPUncertain 1-7.894In-Between0.348AmbiguousLikely Benign0.294Likely Benign-0.31Likely Benign0.10.63Ambiguous0.16Likely Benign0.13Likely Benign-3.14Deleterious0.909Possibly Damaging0.889Possibly Damaging3.43Benign0.02Affected3.471011-1.028.06270.3-52.90.00.00.00.1XPotentially PathogenicThe carboxamide side chain of Gln702 is located at the end and outer surface of an α-helix (res. Leu685-Gln702), where it does not directly form hydrogen bonds with any residues in the WT simulations. In the variant simulations, the positively charged guanidinium group of Arg702 forms a salt bridge with the negatively charged carboxylate group of Glu698 on the same helix and/or hydrogen bonds with the backbone carbonyl group of Ala438 on an opposite α-helix (res. Tyr428-Glu436). Consequently, the residue swap could strengthen the tertiary structure assembly, which could have either positive or negative effects on its function.
c.3125A>GQ1042RLikely BenignUncertain 26-33443677-A-G21.24e-6-2.928Likely Benign0.413AmbiguousLikely Benign0.300Likely Benign-1.39Neutral0.586Possibly Damaging0.120Benign5.48Benign0.12Tolerated3.77511-1.028.06
c.3773A>GQ1258RLikely PathogenicCoiled-coilUncertain 1-10.971Likely Pathogenic0.931Likely PathogenicAmbiguous0.316Likely Benign-3.19Deleterious0.994Probably Damaging0.988Probably Damaging2.00Pathogenic0.00Affected11-1.028.06
c.1199T>AV400E
(3D Viewer)
Likely PathogenicC2Uncertain 1-13.686Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.810Likely Pathogenic3.70Destabilizing0.22.46Destabilizing3.08Destabilizing2.29Destabilizing-4.88Deleterious0.920Possibly Damaging0.335Benign5.31Benign0.00Affected3.3827-2-2-7.729.98249.1-38.8-0.10.11.00.0XXXPotentially PathogenicThe iso-propyl side chain of Val400, located in an anti-parallel β sheet strand (res. Ala399-Ile411), hydrophobically packs against hydrophobic residues within the anti-parallel β sheet of the C2 domain (e.g., Ile268, Ala404, Leu325, Leu402). In the variant simulations, the negatively charged carboxylate group of the Glu400 side chain is not suitable for occupying the hydrophobic niche. Consequently, the side chain escapes the center of the C2 domain and interacts with the backbone amide groups of Leu402 in the same β strand and/or Ile269 and Glu270 in a neighboring β strand (res. Arg259-Arg272). This residue swap disrupts the hydrophobic packing and generally has extensive negative effects on the C2 domain structure. At a minimum, the residue swap could affect the C2 domain stability and membrane association.
c.269T>AV90ELikely BenignUncertain 1-4.079Likely Benign0.703Likely PathogenicLikely Benign0.108Likely Benign-0.38Neutral0.001Benign0.000Benign4.00Benign0.00Affected4.321-2-2-7.729.98
c.3806T>AV1269ELikely PathogenicCoiled-coilUncertain 1-11.418Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.403Likely Benign-5.05Deleterious0.999Probably Damaging0.995Probably Damaging2.09Pathogenic0.00Affected3.775-2-2-7.729.98
c.1030G>AG344S
(3D Viewer)
Likely PathogenicC2Pathogenic 5-11.254Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.790Likely Pathogenic9.02Destabilizing0.76.08Destabilizing7.55Destabilizing0.98Ambiguous-5.28Deleterious1.000Probably Damaging1.000Probably Damaging-0.45Pathogenic0.04Affected3.372510-0.430.03217.3-51.70.00.10.20.1XXPotentially PathogenicBecause Gly344 lacks a proper side chain, it allows the anti-parallel β sheet strand (res. Gly341-Pro349) to have a slight twist. Within a β strand, side chains normally alternate between outward and inward positions, but glycine is an exception as it allows the alternating pattern to skip a residue. Introducing serine or any other residue with a side chain at position 344 prevents this unique skip in the alternating pattern, causing structural strain or likely preventing correct folding altogether. Additionally, Tyr342 shields Gly344 from the solvent, contributing to twist formation in the β sheet and stabilizing the β-strand.In the variant simulations, the side chain of Ser344 assumes the inward position. However, the hydrophobic niche formed by multiple C2 domain residues (e.g., Val365, Val343, Leu327) is not accommodating for its hydroxyl group. The outward position, not seen in the simulations, would be equally disadvantageous due to the presence of hydrophobic residues on that side as well (e.g., Leu345, Tyr342). Serine is also not well-suited for twist formation, as it tends to suppress twisting and bending in β sheets. At this position, the hydroxyl group of Ser344 could also form hydrogen bonds with the backbone atoms of the Gly-rich Ω loop in the C2 domain (e.g., Thr366, Leu367, Gly378; res. Pro364-Pro398), potentially adversely affecting membrane-loop dynamics and ultimately compromising the stability of the SynGAP-membrane association.
c.1108G>AG370S
(3D Viewer)
Likely BenignC2Uncertain 16-33438013-G-A159.31e-6-3.533Likely Benign0.081Likely BenignLikely Benign0.282Likely Benign2.83Destabilizing2.01.05Ambiguous1.94Ambiguous-0.02Likely Benign0.47Neutral0.000Benign0.000Benign1.33Pathogenic0.77Tolerated3.421910-0.430.03196.6-49.60.92.2-0.10.4UncertainGly370 is located in the Gly-rich Ω loop (res. Pro364- Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because, the Ω loop is assumed to be directly interacting with the membrane, it is only seen to move arbitrarily throughout the WT solvent simulations. The Ω loop is potentially playing a crucial loop in the SynGAP-membrane complex association, stability and dynamics, regardless, this aspect cannot be addressed through the solvent simulations only. The Ω-loops are known to have a major role in protein functions that requires flexibility and thus, they are rich in glycines, prolines and to a lesser extent, hydrophilic residues to ensure maximum flexibility. Thus, Ser370 in the variant is potentially tolerated in the Ω loop. However, since the effect on the Gly-rich Ω loop dynamics can only be well-studied through the SynGAP-membrane complex, no definite conclusions can be withdrawn.
c.127G>AG43SLikely BenignUncertain 26-33423536-G-A16.20e-7-3.301Likely Benign0.078Likely BenignLikely Benign0.057Likely Benign-0.30Neutral0.162Benign0.096Benign4.29Benign0.00Affected4.32110-0.430.03
c.1150G>AG384S
(3D Viewer)
Likely BenignC2Uncertain 16-33438055-G-A16.22e-7-5.243Likely Benign0.090Likely BenignLikely Benign0.315Likely Benign1.92Ambiguous0.21.66Ambiguous1.79Ambiguous0.19Likely Benign-0.67Neutral0.980Probably Damaging0.968Probably Damaging1.33Pathogenic0.04Affected4.32210-0.430.03202.4-49.80.51.0-0.20.0UncertainGly384 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and so they are rich in glycines, prolines, and, to a lesser extent, small hydrophilic residues to ensure maximum flexibility. Thus, the variant’s Ser384 is potentially tolerated in the Ω loop, although the hydroxyl group of Ser384 forms various hydrogen bonds with several other loop residues in the variant simulations. However, since the effects on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1405G>AA469T
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.540Likely Pathogenic0.723Likely PathogenicLikely Benign0.527Likely Pathogenic2.26Destabilizing0.11.90Ambiguous2.08Destabilizing0.34Likely Benign-1.46Neutral0.994Probably Damaging0.986Probably Damaging-1.21Pathogenic0.42Tolerated10-2.530.03
c.1195G>AA399T
(3D Viewer)
Likely BenignC2Benign 1-5.236Likely Benign0.114Likely BenignLikely Benign0.272Likely Benign1.24Ambiguous0.10.91Ambiguous1.08Ambiguous0.49Likely Benign-0.40Neutral0.131Benign0.039Benign5.41Benign0.69Tolerated3.382610-2.530.03211.4-41.40.00.00.60.4XPotentially PathogenicThe methyl group of Ala399, located in an anti-parallel β sheet strand (res. Ala399-Ile411), is swapped for a hydroxyl-containing threonine. In the variant simulations, the hydroxyl group of Thr399 can form H-bonds with the backbone atoms of the residues in the membrane-facing loops (e.g., Gly382) in the C2 domain. Consequently, the ability of the Thr399 side chain to form H-bonds with the membrane-facing loops could adversely affect the dynamics and stability of the SynGAP-membrane association. However, since the effects on the dynamics of the membrane-facing loops can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1285C>TR429W
(3D Viewer)
GAPConflicting 56-33438190-C-T654.03e-5-10.666Likely Pathogenic0.500AmbiguousLikely Benign0.282Likely Benign0.31Likely Benign0.1-0.13Likely Benign0.09Likely Benign0.52Ambiguous-3.19Deleterious1.000Probably Damaging0.990Probably Damaging3.41Benign0.03Affected3.38252-33.630.03252.345.50.00.00.20.1XPotentially PathogenicThe guanidinium group of Arg429, located in an α helix (res. Met414-Glu436), either forms a salt bridge with the carboxylate group of an acidic residue (Asp474, Asp467) or a H-bond with the hydroxyl group of Ser471 in an opposing α helix (res. Ala461-Phe476). In the variant simulations, the indole ring of the Trp429 side chain cannot form ionic interactions with the acidic residues. Although it forms a H-bond with Ser471, the bonding is not as strong as that of arginine. The residue swap could affect the tertiary structure assembly during folding; however, no large-scale negative effects were seen during the simulations.
c.1312G>AA438T
(3D Viewer)
Likely BenignGAPConflicting 36-33438217-G-A169.91e-6-5.339Likely Benign0.085Likely BenignLikely Benign0.021Likely Benign0.21Likely Benign0.0-0.07Likely Benign0.07Likely Benign0.36Likely Benign-0.81Neutral0.300Benign0.011Benign4.18Benign0.14Tolerated3.382610-2.530.03214.2-42.7-0.30.1-0.40.1XPotentially BenignThe methyl group of Ala438, located in a four-residue loop connecting two α helices (res. Asn440-Thr458 and Pro413-Glu436), packs against hydrophobic residues from a nearby α helix or loop residues (e.g., Leu703, Val699). In the variant simulations, the methyl group of Thr438 is able to establish similar hydrophobic packing. Moreover, the hydroxyl group also H-bonds with nearby residues, such as the carbonyl group of the neighboring loop residue Pro437. Accordingly, the residue swap does not generate an apparent negative effect on the protein structure based on the simulations.
c.1423C>TR475W
(3D Viewer)
Likely PathogenicGAPUncertain 16-33438455-C-T16.20e-7-13.235Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.725Likely Pathogenic1.44Ambiguous0.4-0.92Ambiguous0.26Likely Benign0.56Ambiguous-7.56Deleterious1.000Probably Damaging0.995Probably Damaging-1.45Pathogenic0.00Affected3.39282-33.630.03266.939.60.00.00.00.1XXXPotentially PathogenicIn the WT simulations, the guanidinium group of Arg475, located near the end of an α-helix (res. Ala461-Phe476), stacks with the phenyl ring of Phe476 and forms a salt bridge with Glu472. Additionally, Arg475 occasionally forms another salt bridge with the carboxylate group of Glu486 on the α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. Therefore, Arg475 potentially plays a key role in positioning the loop by interacting with Glu486, which is necessary for the positioning of the “arginine finger” (Arg485) and, ultimately, for RasGTPase activation.In the variant simulations, Trp475 moves and stacks with Arg479 on the proceeding α-α loop, disrupting the terminal end of the α-helix. Lastly, the potential effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1738G>AG580S
(3D Viewer)
Likely PathogenicGAPUncertain 16-33440790-G-A16.20e-7-10.788Likely Pathogenic0.861Likely PathogenicAmbiguous0.644Likely Pathogenic2.84Destabilizing0.20.59Ambiguous1.72Ambiguous0.87Ambiguous-5.73Deleterious1.000Probably Damaging0.999Probably Damaging-1.23Pathogenic0.07Tolerated3.373410-0.430.03233.9-49.30.80.00.60.1XPotentially BenignGly580 is located on the outer surface in a short α-α loop turn connecting two α-helices (res. Arg563-Glu578, res. Glu582-Phe608) in the WT simulations. In the variant simulations, the side chain of Ser580 faces outward, and its hydroxyl group does not make any new or additional interactions compared to Gly580 in the WT simulations that could affect the protein structure.
c.1717C>TR573W
(3D Viewer)
Likely PathogenicGAPConflicting 8-14.078Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.758Likely Pathogenic2.37Destabilizing0.70.57Ambiguous1.47Ambiguous0.88Ambiguous-6.94Deleterious1.000Probably Damaging0.997Probably Damaging-1.48Pathogenic0.00Affected3.37352-33.630.03257.639.00.10.00.20.0XXPotentially PathogenicThe guanidinium group of Arg573, located in an α-helix (res. Arg563-Glu578), forms a salt bridge with the carboxylate groups of Glu582 and/or Asp586 from a nearby α-helix (res. Glu582-Met603) in the WT simulations. Additionally, the Arg573 side chain stacks planarly with the aromatic phenol ring of Tyr665 and hydrogen bonds with the hydroxyl group of Ser668 from another α-helix (res. Ser641-Ser668). In the variant simulations, the indole ring of the Trp573 side chain is unable to maintain the same level of coordination as the positively charged Arg573 side chain. Indeed, Trp573 is seen hydrogen bonding only briefly with the carboxylate group of Glu582. Consequently, the integrity of the opposing α-helix end (res. Glu582-Met603) is weakened. Overall, the residue swap has the potential to substantially affect the tertiary structure assembly during the protein folding process.
c.1729G>AA577T
(3D Viewer)
Likely BenignGAPBenign 16-33440781-G-A63.72e-6-5.311Likely Benign0.322Likely BenignLikely Benign0.427Likely Benign0.86Ambiguous0.10.54Ambiguous0.70Ambiguous0.54Ambiguous-1.47Neutral0.999Probably Damaging0.987Probably Damaging-1.31Pathogenic0.47Tolerated3.373410-2.530.03191.9-43.40.00.00.70.1XPotentially BenignAla577 is located near the end and outer surface of an α-helix (res. Arg563-Glu578), where its methyl group does not form any particular interactions in the WT simulations. In the variant simulations, the hydroxyl group of the Thr577 side chain hydrogen bonds with the backbone atoms of Arg573 and Lys574 within the same helix, which has the potential to weaken the stability of the secondary structure element. Regardless, the residue swap seems to be well tolerated based on the variant simulations.
c.1741C>TR581W
(3D Viewer)
Likely PathogenicGAPUncertain 2-12.855Likely Pathogenic0.920Likely PathogenicAmbiguous0.678Likely Pathogenic1.32Ambiguous0.1-0.32Likely Benign0.50Ambiguous0.68Ambiguous-6.79Deleterious1.000Probably Damaging0.997Probably Damaging-1.37Pathogenic0.01Affected3.37342-33.630.03257.836.00.10.10.10.3XXPotentially PathogenicArg581 is located on a short α-α loop between two α helices (res. Arg563-Glu578 and res. Glu582-Ser604). In the WT simulations, the guanidinium group of Arg581 forms salt bridges with the carboxylate groups of Asp583 within the same helix, as well as with Glu478 and/or Glu480 in a slightly α-helical loop (res. Glu478-Thr488) preceding another α helix (res. Ala461-Phe476).In the variant simulations, the neutral indole ring of the Trp581 side chain cannot form any of these salt bridges. Instead, it packs hydrophobically against Met477 and Ile587 without forming any direct hydrogen bonds. The tendency of the loop (res. Asp477-Thr488) to acquire an α-helical structure seems to marginally increase, potentially due to Trp581's inability to coordinate stable hydrogen bonds with the loop residues (e.g., Glu478-Arg581 salt bridge). Additionally, the residue swap could weaken the tertiary structure assembly and negatively affect the overall protein folding process.
c.2218C>TR740WUncertain 26-33441683-C-T63.72e-6-8.561Likely Pathogenic0.168Likely BenignLikely Benign0.180Likely Benign-3.09Deleterious1.000Probably Damaging0.938Probably Damaging2.52Benign0.01Affected4.3222-33.630.03
c.2224C>TR742WLikely BenignUncertain 16-33441689-C-T63.72e-6-7.725In-Between0.133Likely BenignLikely Benign0.079Likely Benign-1.71Neutral0.992Probably Damaging0.684Possibly Damaging2.66Benign0.01Affected4.322-323.630.03
c.2245C>TR749WLikely Benign 16-33441710-C-T31.86e-6-7.647In-Between0.338Likely BenignLikely Benign0.173Likely Benign-2.62Deleterious1.000Probably Damaging0.998Probably Damaging2.59Benign0.00Affected4.3222-33.630.03
c.1771G>AA591T
(3D Viewer)
Likely PathogenicGAPConflicting 36-33440823-G-A181.12e-5-9.572Likely Pathogenic0.704Likely PathogenicLikely Benign0.270Likely Benign1.61Ambiguous0.21.00Ambiguous1.31Ambiguous1.19Destabilizing-3.40Deleterious0.955Possibly Damaging0.209Benign3.48Benign0.01Affected3.373510-2.530.03202.9-43.40.20.00.70.1XPotentially BenignThe methyl group of the Ala591 side chain, located in the middle of an α helix (res. Glu582-Met603), packs against hydrophobic residues (e.g., Ile483, Phe484) of an opposing partially helical loop (res. Phe476-Asn487).In the variant simulations, the hydroxyl group of Thr591 can form hydrogen bonds with the backbone carbonyl of Ile843 in the opposing loop or the backbone carbonyl group of Arg587. These interactions could either reinforce the tertiary assembly or weaken the α helix unity. Additionally, the Thr591 side chain can hydrogen bond with the guanidinium group of the Arg587 side chain, potentially strengthening the α helix unity.Overall, the residue swap does not seem to cause any major negative effects on the protein structure.
c.2350G>AA784TLikely BenignBenign 1-3.579Likely Benign0.089Likely BenignLikely Benign0.046Likely Benign1.23Neutral0.001Benign0.006Benign2.92Benign1.00Tolerated3.64610-2.530.03
c.2401G>AG801SLikely BenignSH3-binding motifUncertain 1-3.665Likely Benign0.087Likely BenignLikely Benign0.039Likely Benign-0.41Neutral0.009Benign0.019Benign2.76Benign0.48Tolerated4.32201-0.430.03
c.2623G>AA875TLikely BenignUncertain 16-33443175-G-A16.20e-7-3.793Likely Benign0.179Likely BenignLikely Benign0.110Likely Benign-1.56Neutral0.972Probably Damaging0.864Possibly Damaging2.72Benign0.26Tolerated3.77501-2.530.03
c.2650C>TR884WLikely BenignUncertain 16-33443202-C-T53.10e-6-3.785Likely Benign0.332Likely BenignLikely Benign0.151Likely Benign0.26Neutral0.995Probably Damaging0.812Possibly Damaging2.56Benign0.05Affected4.324-323.630.03
c.2704G>AA902TLikely BenignLikely Benign 16-33443256-G-A362.23e-5-4.966Likely Benign0.116Likely BenignLikely Benign0.075Likely Benign-1.11Neutral0.951Possibly Damaging0.617Possibly Damaging2.61Benign0.01Affected3.77510-2.530.03
c.2743G>AG915SLikely BenignBenign 16-33443295-G-A95.58e-6-3.557Likely Benign0.083Likely BenignLikely Benign0.050Likely Benign-0.88Neutral0.801Possibly Damaging0.201Benign2.73Benign0.31Tolerated3.77510-0.430.03
c.2752G>AA918TLikely BenignUncertain 16-33443304-G-A16.20e-7-4.139Likely Benign0.083Likely BenignLikely Benign0.065Likely Benign-1.09Neutral0.980Probably Damaging0.721Possibly Damaging2.64Benign0.03Affected4.32401-2.530.03
c.2818G>AG940SLikely BenignUncertain 16-33443370-G-A16.20e-7-5.451Likely Benign0.084Likely BenignLikely Benign0.135Likely Benign0.45Neutral0.409Benign0.253Benign2.77Benign0.44Tolerated3.77510-0.430.03
c.2830G>AG944SLikely BenignBenign 16-33443382-G-A138.05e-6-5.303Likely Benign0.082Likely BenignLikely Benign0.223Likely Benign-0.75Neutral0.007Benign0.004Benign3.77Benign0.00Affected4.32410-0.430.03
c.2845G>AG949SLikely BenignBenign/Likely benign 46-33443397-G-A1227.56e-5-5.693Likely Benign0.072Likely BenignLikely Benign0.321Likely Benign0.30Neutral0.611Possibly Damaging0.102Benign2.23Pathogenic0.00Affected4.32410-0.430.0310.1016/j.ajhg.2020.11.011

Found 757 rows. Show 200 rows per page. Page 3/4 |